Patents by Inventor Lin Ping

Lin Ping has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Treatment of type 2 diabetes mellitus patients
    Patent number: 10159713
    Abstract: The present invention refers to lixisenatide for use in the reduction of progression of urinary albumin excretion in a type 2 diabetes mellitus patient.
    Type: Grant
    Filed: March 17, 2016
    Date of Patent: December 25, 2018
    Assignee: Sanofi-Aventis Deutschland GmbH
    Inventors: Rene Belder, Peter Johnston, Francesca Lawson, Lin Ping, Xiaodan Wei
  • Treatment of Type 2 Diabetes Mellitus Patients
    Publication number: 20180243379
    Abstract: The present invention refers to lixisenatide for use in the reduction of progression of urinary albumin excretion in a type 2 diabetes mellitus patient.
    Type: Application
    Filed: February 9, 2018
    Publication date: August 30, 2018
    Inventors: Rene Belder, Peter Johnston, Francesca Lawson, Lin Ping, Xiaodan Wei
  • Treatment of Type 2 Diabetes Mellitus Patients
    Publication number: 20160296601
    Abstract: The present invention refers to lixisenatide for use in the reduction of progression of urinary albumin excretion in a type 2 diabetes mellitus patient.
    Type: Application
    Filed: March 17, 2016
    Publication date: October 13, 2016
    Inventors: Rene Belder, Peter Johnston, Francesca Lawson, Lin Ping, Xiaodan Wei